Total Funding
75
15
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
465455
Hemera Biosciences develops anti-complement gene-based therapies for the treatment of dry and wet age-related macular degeneration.
About the Company
Hemera Biosciences Inc. is a privately held biotechnology company founded in 2010. Our primary mission is to develop anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration (AMD). AMD is the most common cause of blindness amongst the elderly with no treatment options currently available for 90% of
patients that suffer from the dry form of the disease. Using our proprietary recombinant molecules, we have demonstrated a very significant reduction in complement mediated damage to ocular tissues in preclinical models of dry as well as wet AMD.
